To start off the New Year, the Glaucoma Research Foundation marks January as Glaucoma awareness month. Glaucoma is second to cataracts as a leading cause of global blindness and is the leading cause of irreversible visual loss. Globally, there are an estimated 60 million people with glaucomatous optic neuropathy and an estimated 8.4 million people who are blind as the result of glaucoma. These numbers are set to increase to 80 million and 11.2 million respectively, by 2020 due to population ageing.
The term “Glaucoma” is used to describe a number of different eye conditions characterised by damage to the optic nerve caused by the build up of pressure inside the eye. The two main types of glaucoma are Open-Angle glaucoma which causes vision to become progressively impaired over many years, and Angle-Closure glaucoma where there is a sudden build up of pressure in the eye which can rapidly lead to permanent loss of vision if not treated quickly.
To really understand this disease area, the Epiomic database depicts the population incidence by segmenting Glaucoma by eye laterality and type of glaucoma. Delving deeper, the database presents data regarding the most commonly associated co-morbid conditions such as diabetes and hypertension, which will be critical when addressing specific populations.
Open angle glaucoma patients are significantly more likely to have co morbidities than any other type of glaucoma.